NDC 66277-338 - Epuris
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66277-338
- Package NDCs from labels
- 66277-338-10, 66277-338-30
- Manufacturer
- Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc
- Effective date
- 2024-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Epuris - Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc | Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc | 2024-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66277-338-10 | Epuris | 10 in 1 BLISTER PACK | CAPSULE | 10 | 2 | |
| 66277-338-30 | Epuris | 3 in 1 BOX | CAPSULE | 3 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ISOTRETINOIN | ISOTRETINOIN | Aurobindo Pharma Limited | 4e8516dc-a3c6-4d8f-aa14-2c37c6c8f6e6 | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Amneal Pharmaceuticals LLC | c2917c3d-3499-48a0-ba53-120cb979195d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Zydus Pharmaceuticals USA Inc. | 31f62a49-4c6d-4ce3-a0ca-d159562370b1 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Actavis Pharma, Inc. | 1cf11710-f966-4529-8e08-02175f588bca | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Absorica LD | ISOTRETINOIN | Sun Pharmaceutical Industries, Inc. | 3ef0cff8-19c1-4441-b780-fca6c7ee1615 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Amnesteem | ISOTRETINOIN | Mylan Pharmaceuticals Inc. | b2cb63c9-f825-4991-9a2c-6260f1bbcc2c | 2026-08-15 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Claravis | ISOTRETINOIN | Teva Pharmaceuticals USA, Inc. | a31fd109-d0fd-4ab9-ba98-a3d64333c18d | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| NutriLipid I.V. Fat Emulsion | SOYBEAN OIL | B. Braun Medical Inc. | 193290b1-a0a1-4054-a22a-de5c9e7a8b73 | 2026-07-10 | Warnings, Adverse reactions | 241ATL177A |
| Isotretinoin | ISOTRETINOIN | Zydus Pharmaceuticals USA Inc. | 28948c32-a598-4bb5-bdb5-efbd87214d98 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| ZENATANE | ISOTRETINOIN | BluePoint Laboratories | 486d4a4b-0de5-431a-bef7-dae6b0e4fa20 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Upsher-Smith Laboratories, LLC | 08529687-26b2-41e5-b6fb-35b4c0d891fe | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Upsher-Smith Laboratories, LLC | c369e1c3-90c5-4768-9741-56c62253a2c4 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| ACCUTANE | ISOTRETINOIN | JG Pharma Inc. | 5b524a51-a16b-496e-b764-11c98c479c36 | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Intralipid | I.V. FAT EMULSION | ProPharma Distribution | 48c12fbe-c5e8-a1fc-e063-6294a90a15ae | 2026-01-19 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 61e025f1-a38e-4af2-9e18-13ea12977cf5 | 2025-11-19 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | ProPharma Distribution | 42dffe5a-892b-03ec-e063-6394a90ae50c | 2025-11-05 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | 98460eae-5195-48d2-ab73-00d276879ef6 | 2025-10-09 | Warnings, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Fresenius Kabi USA, LLC | bdcc364b-77b2-4939-8add-03e5396d46c2 | 2025-10-08 | Warnings, Adverse reactions | 241ATL177A |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 241ATL177A |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 241ATL177A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.